Accelerating

Scientific Decisions^™

The Cannabinoid Type 1 Receptor (CB1R) is highly expressed in the central nervous system, but also in skeletal muscles, gastrointestinal tract, liver, pancreas, skin, reproductive system, and cardiovascular system. The CB1R is involved in a wide range of physiological and pathophysiological processes related to neurological disorders, energy metabolism, obesity, diabetes, cardiovascular and reproductive disorders, inflammation, and cancer.

Our Nuclear Receptor Assay products are cell-based reporter assay systems that feature engineered nuclear receptor-specific reporter cells prepared using our unique CryoMite™ process. Our nuclear receptor reporter assays are optimally configured for processing in 96- and 384- well format assay plates. Single plate kits (3x 32-, 1x 96-, and 1x 384-well) are offered as all-inclusive assay systems, including nuclear receptor reporter cells, an assay plate, all required reagents, and detailed technical manual. Get what you need from the world’s largest portfolio of nuclear receptor assays.

Our In Vitro Toxicology platform meets the increasing demand for more predictive models for liver toxicity due to the fact that hepatotoxicity remains a major reason for drug withdrawal from pharmaceutical development and clinical use. A primary application of this platform is to screen chemicals for induction and activity of hepatic drug metabolizing enzymes (DME). The platform utilizes upcyte® human liver cells to assess chemical and drug-induced toxicity. Learn about our In Vitro Toxicology platform featuring predictive liver toxicity models.

Request a quote for nuclear receptor assay panels, kits or services, or in vitro toxicology solutions

See some of our latest Scientific Posters related to Nuclear Receptors, Nuclear Receptor research, In Vitro Toxicology, and Gene Expression.

Scientific studies, scholarly articles, and patent information on Nuclear Receptors and Nuclear Receptor research.